Evidence map›Paper›PMID 34123365›Full record

ArticleClinical and translational allergy2021

The influence of individual characteristics and non-respiratory diseases on blood eosinophil count.

Rita Amaral, Tiago Jacinto, Andrei Malinovschi, Christer Janson, David Price, João A Fonseca, Kjell Alving

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational allergy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 4 countries.

Rita AmaralCINTESIS-Center for Health Technology and Services Research Faculty of Medicine University of Porto Porto Portugal.ORCID https://orcid.org/0000-0002-0233-830X
Tiago JacintoCINTESIS-Center for Health Technology and Services Research Faculty of Medicine University of Porto Porto Portugal.
Andrei MalinovschiDepartment of Medical Sciences Clinical Physiology Uppsala University Uppsala Sweden.ORCID https://orcid.org/0000-0002-4098-7765
Christer JansonDepartment of Medical Sciences Respiratory, Allergy and Sleep Research Uppsala University Uppsala Sweden.
David PriceObservational and Pragmatic Research Institute Singapore Singapore.
João A FonsecaCINTESIS-Center for Health Technology and Services Research Faculty of Medicine University of Porto Porto Portugal.
Kjell AlvingDepartment of Women's and Children's Health Paediatric Research Uppsala University Uppsala Sweden.
Uppsala University · SEUniversidade do Porto · PTUniversity of Aberdeen · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlood eosinophil (B-Eos) count is an emerging biomarker in the management of respiratory disease but determinants of B-Eos count besides respiratory disease are poorly described. Therefore, we aimed to evaluate the influence of non-respiratory diseases on B-Eos count, in comparison to the effect on two other biomarkers: fraction of exhaled nitric oxide (FeNO) and C-reactive protein (CRP), and to identify individual characteristics associated with B-Eos count in healthy controls.

methodsChildren/adolescents (<18 years) and adults with complete B-Eos data from the US National Health and Nutritional Examination Surveys 2005-2016 were included, and they were divided into having respiratory diseases (

resultsIn adults, metabolic syndrome, heart disease or stroke was independently associated with higher B-Eos count (12%, 13%, and 15%, respectively), whereas no associations were found with FeNO or CRP. In healthy controls, male sex or being obese was associated with higher B-Eos counts, both in children/adolescents (15% and 3% higher, respectively) and adults (14% and 19% higher, respectively) (

conclusionsNon-respiratory diseases influence B-Eos count but not FeNO or CRP. Male sex, obesity, certain races/ethnicities, and current smoking are individual characteristics or exposures that are associated with higher B-Eos counts. All these factors should be considered when using B-Eos count in the management of respiratory disease.

Indexed as

airway inflammationblood eosinophilseosinophilic inflammationrespiratory diseases

Identifiers

PMID34123365
PMCPMC8175041
OpenAlexW3166563710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.